2023-03-02 | Purchase | Recursion Pharmaceuticals, Inc. RXRX | 10 percent owner | | $7.82 | $522,354 | +1.44% | |
2023-03-01 | Purchase | Recursion Pharmaceuticals, Inc. RXRX | 10 percent owner | | $7.94 | $388,082 | +2.14% | |
2023-02-28 | Purchase | Recursion Pharmaceuticals, Inc. RXRX | 10 percent owner | | $7.97 | $6,496 | -0.86% | |
2023-02-27 | Purchase | Recursion Pharmaceuticals, Inc. RXRX | 10 percent owner | | $7.69 | $403,725 | +4.66% | |
2023-02-24 | Purchase | Recursion Pharmaceuticals, Inc. RXRX | 10 percent owner | | $7.64 | $833,552 | +5.26% | |
2023-02-23 | Purchase | Recursion Pharmaceuticals, Inc. RXRX | 10 percent owner | | $7.79 | $403,792 | +1.78% | |
2023-02-22 | Purchase | Recursion Pharmaceuticals, Inc. RXRX | 10 percent owner | | $7.83 | $399,016 | +0.25% | |
2023-02-21 | Purchase | Recursion Pharmaceuticals, Inc. RXRX | 10 percent owner | | $7.74 | $731,126 | +3.05% | |
2023-02-17 | Purchase | Recursion Pharmaceuticals, Inc. RXRX | 10 percent owner | | $7.71 | $488,986 | -0.88% | |
2023-02-16 | Purchase | Recursion Pharmaceuticals, Inc. RXRX | 10 percent owner | | $7.90 | $337,043 | +1.41% | |
2023-02-14 | Purchase | Recursion Pharmaceuticals, Inc. RXRX | 10 percent owner | | $7.95 | $50,060 | -5.34% | |
2023-02-13 | Purchase | Recursion Pharmaceuticals, Inc. RXRX | 10 percent owner | | $7.97 | $258,837 | -1.19% | |
2023-02-10 | Purchase | Recursion Pharmaceuticals, Inc. RXRX | 10 percent owner | | $7.98 | $87,808 | -4.15% | |
2023-02-01 | Purchase | Recursion Pharmaceuticals, Inc. RXRX | 10 percent owner | | $7.97 | $4,782 | -7.78% | |
2023-02-01 | Purchase | Recursion Pharmaceuticals, Inc. RXRX | 10 percent owner | | $7.97 | $9,564 | -7.78% | |
2023-01-26 | Purchase | Recursion Pharmaceuticals, Inc. RXRX | director | | $7.99 | $63,006 | -3.72% | |
2023-01-26 | Purchase | Recursion Pharmaceuticals, Inc. RXRX | director | | $7.99 | $126,012 | -3.72% | |
2023-01-25 | Purchase | Recursion Pharmaceuticals, Inc. RXRX | director | | $7.88 | $193,267 | -4.08% | |
2023-01-25 | Purchase | Recursion Pharmaceuticals, Inc. RXRX | director | | $7.88 | $386,535 | -4.08% | |
2023-01-10 | Purchase | Recursion Pharmaceuticals, Inc. RXRX | director | | $7.72 | $536,846 | +1.22% | |